The global MRNA Therapy market report offers a comprehensive assessment of the market. It provides in-depth analysis through qualitative information, historical data, and verifiable projections about the size of the market. The projections presented in the report were derived using proven research methodologies and assumptions. The report contains a detailed analysis of the MRNA Therapy market growth, segmentation, and breakdowns by region and country. Can provide detailed study of drivers, development strategies, SWOT analysis and the impact of Covid-19 and the recovery of growth. This research will give a clear and precise idea about the general market to the readers for them to make beneficial decisions.
The global mRNA Therapy market is projected to reach USD ~35 billion by 2029 from USD 32 billion in 2023, at a CAGR of ~2.1% between 2023 and 2029.
Get the sample PDF copy (including FULL TOC, graphs and tables) of this report @
The most prominent players in the market are:
Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc., Astrazeneca, CureVac and others.
mRNA Therapy Market News
November 2022: Health Canada authorized the use of the Moderna Spikevax 50 mcg BA.4/5 bivalent COVID-19 vaccine as a booster dose in individuals aged 18 years and older. Health Canada previously authorized similar bivalent booster doses containing Omicron BA.1 or BA.4/5 variants from Moderna (50 mcg) and Pfizer-BioNTech (30 mcg) in September and October of 2022, respectively.
October 2022: Moderna Inc. reported that it had received emergency use authorization (EUA) from the United States Food and Drug Administration (FDA) for its BA.4/BA.5 Omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.222, in children and adolescents aged 6 to 17 years.
This report provides 360-degree analysis of the Global MRNA Therapy Market. Thus, readers get access to a comprehensive assessment of important factors, including growth drivers, challenges, R&D, and business expansion opportunities in the market during the forecast period, 2023 to 2029.
Global MRNA Therapy Market Segmentation:
According to the type, the market has been segmented into:
According to the application, the market has been segmented into:
mRNA Targeted Delivery in vivo
Genetically Modified T cells
Transforming Nanoparticles to Develop Immunotherapy for Cancer
Small Molecule Drugs Discovery
If you have any questions about the market report, please ask our experts@
For a comprehensive understanding of market dynamics, the market is analysed across key geographies namely: United States, China, Europe, Japan, Southeast Asia, India, and others. Each of these regions is analysed based on the market research results of key countries in these regions to understand the market at a macro level.
Important highlights from the report:
This MRNA Therapy Market research report reveals this business overview, product overview, market share, supply-demand ratio, supply chain analysis, and import/export details.
The industry report captivates different approaches and procedures endorsed by the key market players to make crucial business decisions.
Historical and current data is provided in the report on the basis of which future projections are made and industry analysis is performed.
Porter’s Five Forces Analysis, Value Chain Analysis, and SWOT Analysis are some additional important parameters that are used for market growth analysis.
The MRNA Therapy report provides clients with facts and figures about the market on the basis of assessment of the industry through primary and secondary research methodologies.
Strategic Points Covered in Table of Contents of Global MRNA Therapy Market:
- Market segmentation
- Executive Summary
- Premium insights
- Global MRNA Therapy Market – Regulations
- Market overview
- Global MRNA Therapy Market, by Supply
- Global MRNA Therapy Market, by Type and by End User
- Global market, by region
- Global Market: Company Overview
- SWOT and Matrix Analysis
- Company Profile
- Related reports
The report offers details on all current global industry offerings based on a number of areas. Based on the most recent updates, the report incorporates relevant government policy and regulatory developments.
Download to get purchase report:
Reasons to buy this report:
-Offers an analysis of the changing competitive landscape.
-For informed decision making in business, it offers analytical data with strategic planning methodologies.
– Analysis and evaluation of strategic cooperation: Researchers analyze recent strategic activities, such as mergers, acquisitions, partnerships, collaborations, and joint ventures.
-Helps understand the main key product segments.
-Researchers shed light on market dynamics such as drivers, restraints, trends, and opportunities. Provides regional analysis of the MRNA Therapy market along with business profiles of various stakeholders.
-It offers massive data on trending factors that will influence the progress of the MRNA Therapy market.
Report customization options:
With this detailed report, MID offers one of the following free customization options to our respectable customers:
- Company profiling
- Detailed profile of key companies in the market (up to 5 companies)
- SWOT evaluation of key companies in the market (up to 5 companies)
More importantly, this market study can help you identify blind spots in the market.
To establish important features, or to get a custom report related to research, join our sales team at:
Irfan Tamboli (Head of Sales) – market intelligence data
Phone: +1 (704) 266-3234 | +91-750-707-8687
Mail to: email@example.com